Microbiology & Infectious Diseases

A groundbreaking Phase IIa HIV cure study in South Africa has demonstrated the safety and potential efficacy of a novel therapeutic regimen in women with HIV.

Measles cases in the EU/EEA have risen dramatically over the past year, with numbers far exceeding those reported in 2023.

A large-scale genomic surveillance study has found that resistance to nirsevimab in infants remains rare despite widespread use.

A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in a clinical trial involving older adults.

A Phase IIb clinical trial evaluating the tuberculosis vaccine H56:IC31 has found no evidence that it reduces the risk of recurrent disease in individuals who have completed treatment for pulmonary tuberculosis.

The new guidelines address emerging antifungal resistance, recent taxonomic reclassifications, and gaps in existing treatment recommendations.

Findings reveal alarmingly high rates of AMR among bacterial pathogens affecting patients with cancer worldwide.

New research highlights the role of ventilator-capable nursing homes in the spread of antimicrobial-resistant pathogens, including the emerging multidrug-resistant fungus Candida auris.